Biotech RadarJobs updated

COMPANY

Anika Therapeutics

HQ: Bedford, MA source · anika.com ↗ · New England

FDA-cleared device company Clinical Phase 3

14 open jobs · last seen Oct 23, 2026 · 20 sources

Profile checked Oct 10, 2026

Keywords: Knee Osteoarthritis Hip Osteoarthritis Rotator Cuff Tears of the Shoulder Defect of Articular Cartilage Osteo Arthritis Shoulders Osteoarthritis Ankle Shoulder Osteoarthritis Ankle Osteoarthritis Osteoarthritis Epicondylitis Tennis Elbow Epicondylosis Osteoarthritis of the Knee Lateral Epicondylitis Elbow Tendinopathy Wrinkles Monovisc Cingal Integrity Implant System Hyalofast Monovisc® OVT (Sodium Hyaluronate) OrthoVisc®-T Elevess

14Open jobs17Trials (company is sponsor)3FDA records (2 yrs)

Hiring

TitleLocation (from posting)Employer postedFirst seen
QA Compliance SpecialistBedford, MA, Bedford, MA, USOct 17, 2026Oct 17, 2026
Commercial Manager (Metro Atlanta)RemoteOct 14, 2026Oct 14, 2026
Aseptic Manufacturing Sr. Technician 2nd Shift 1:00pm-9:30pmBedford, MA, Bedford, MA, USOct 13, 2026Oct 14, 2026
Aseptic Manufacturing Technician 2nd Shift 1:00pm-9:30pmBedford, MA, Bedford, MA, USOct 13, 2026Oct 14, 2026
Aseptic Manufacturing Shift Lead 2nd Shift 1:00pm-9:30pmBedford, MA, USOct 13, 2026Oct 14, 2026

See all 14 jobs

Timeline

  1. FDA FDA 510(k) clearance: Integrity Retractable Implant Inserter (6000127) — K261869, Sep 17, 2026. Applicant at approval: Anika Therapeutics, Inc. source ↗
  2. FDA FDA 510(k) clearance: HYALOMATRIX — K261311, Sep 2, 2026. Applicant at approval: Anika Therapeutics, Inc. source ↗
  3. Trial start Not phased (device or behavioral study): Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow) source ↗
  4. FDA FDA 510(k) clearance: Integrity™ Implant — K250997, Jun 17, 2025. Applicant at approval: Anika Therapeutics, Inc. source ↗
  5. Trial start Not phased (device or behavioral study): Integrity Implant System Post Market Clinical Follow-Up Study source ↗
  6. Trial start Not phased (device or behavioral study): Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint source ↗
  7. Trial start Not phased (device or behavioral study): Study of Cingal® for Symptomatic Relief of Osteoarthritis of Shoulder Joint source ↗
  8. Trial start Not phased (device or behavioral study): Study of Cingal® for Symptomatic Relief of Osteoarthritis of Ankle Joint source ↗
  9. Trial start Phase 3: Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain source ↗
  10. Trial start Not phased (device or behavioral study): MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis source ↗
  11. Trial start Not phased (device or behavioral study): MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis source ↗
  12. Trial start Not phased (device or behavioral study): MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis source ↗
  13. Trial start Not phased (device or behavioral study): OVT for Epicondylosis (Tennis Elbow) source ↗
  14. Trial start Phase 3: Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up source ↗
  15. Trial start Phase 3: Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide source ↗
  16. Trial start Not phased (device or behavioral study): HyaloFAST Trial for Repair of Articular Cartilage in the Knee source ↗
  17. Trial start Phase 3: Repeat Injection of Cingal® for Osteoarthritis of the Knee source ↗
  18. Trial start Not phased (device or behavioral study): Cingal Study for Knee Osteoarthritis source ↗
  19. Trial start Not phased (device or behavioral study): Safety Study of Cosmetic Tissue Augmentation in People of Color source ↗
  20. Trial start Not phased (device or behavioral study): Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 17

RecordTitlePhaseStatusStartPrimary completion
NCT06741527Integrity Implant System Post Market Clinical Follow-Up StudyNot phased (device or behavioral study)RecruitingFeb 1, 20252027-06 (estimated)
NCT02659215HyaloFAST Trial for Repair of Articular Cartilage in the KneeNot phased (device or behavioral study)Active, not recruiting2015-12Mar 20, 2025 (actual)
NCT04204265MONOVISC for Shoulder Joint Pain Relief Due to OsteoarthritisNot phased (device or behavioral study)CompletedDec 17, 2019Feb 26, 2021 (actual)
NCT04204278MONOVISC for Ankle Joint Pain Relief Due to OsteoarthritisNot phased (device or behavioral study)CompletedDec 11, 2019Feb 26, 2021 (actual)
NCT04204083MONOVISC for Hip Joint Pain Relief Due to OsteoarthritisNot phased (device or behavioral study)CompletedDec 17, 2019Feb 26, 2021 (actual)
NCT04640298Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip JointNot phased (device or behavioral study)CompletedJan 16, 2021Sep 10, 2021 (actual)
NCT04640961Study of Cingal® for Symptomatic Relief of Osteoarthritis of Shoulder JointNot phased (device or behavioral study)CompletedJan 16, 2021Sep 10, 2021 (actual)
NCT04640974Study of Cingal® for Symptomatic Relief of Osteoarthritis of Ankle JointNot phased (device or behavioral study)CompletedJan 14, 2021Sep 24, 2021 (actual)
NCT04231318Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis PainPhase 3CompletedSep 11, 2020May 16, 2022 (actual)
NCT00653432Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the KneeNot phased (device or behavioral study)Completed2008-012009-12 (actual)
NCT01891396Cingal Study for Knee OsteoarthritisNot phased (device or behavioral study)Completed2013-062014-05 (actual)
NCT03390036Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow upPhase 3CompletedDec 7, 2017Jul 30, 2018 (actual)
NCT02861183Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)Not phased (device or behavioral study)Withdrawn2025-092027-04 (estimated)
NCT02381652Repeat Injection of Cingal® for Osteoarthritis of the KneePhase 3Completed2015-022015-04 (actual)
NCT03191903Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone HexacetonidePhase 3CompletedMay 25, 2017Apr 23, 2018 (actual)
NCT04026191OVT for Epicondylosis (Tennis Elbow)Not phased (device or behavioral study)CompletedJul 19, 2019Dec 31, 2020 (actual)
NCT01147172Safety Study of Cosmetic Tissue Augmentation in People of ColorNot phased (device or behavioral study)Completed2009-032009-12 (actual)

FDA records (last 2 years)

Open jobs 14

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
QA Compliance SpecialistBedford, MA, Bedford, MA, USOct 17, 2026Oct 17, 2026Not stated
Commercial Manager (Metro Atlanta)RemoteOct 14, 2026Oct 14, 2026Mid
Aseptic Manufacturing Sr. Technician 2nd Shift 1:00pm-9:30pmBedford, MA, Bedford, MA, USOct 13, 2026Oct 14, 2026Senior
Aseptic Manufacturing Technician 2nd Shift 1:00pm-9:30pmBedford, MA, Bedford, MA, USOct 13, 2026Oct 14, 2026Entry
Aseptic Manufacturing Shift Lead 2nd Shift 1:00pm-9:30pmBedford, MA, USOct 13, 2026Oct 14, 2026Senior
Commercial Manager (Northeast)RemoteOct 13, 2026Oct 14, 2026Mid
Aseptic Manufacturing Technician, 1st Shift: 6:00am-2:30pmBedford, MA, Bedford, MA, USOct 1, 2026Oct 11, 2026Entry
Regulatory Affairs Project Manager/Sr. ManagerBedford, MA, Bedford, MA, USOct 1, 2026Oct 11, 2026Mid
Calibration SupervisorBedford, MA, USSep 16, 2026Oct 11, 2026Senior
Senior Manager, Quality ControlBedford, MA, Bedford, MA, USAug 26, 2026Oct 11, 2026Senior
Regulatory Affairs Specialist IIBedford, MA, Bedford, MA, USAug 26, 2026Oct 11, 2026Mid
Senior QC Incoming InspectorBedford, MA, USJun 10, 2026Oct 11, 2026Senior
Senior Quality EngineerBedford, MA, Bedford, MA, USMar 25, 2026Oct 11, 2026Senior
Manufacturing Technician (HYAFF), 1st Shift 6:00am-2:30pmBedford, MA, Bedford, MA, USJan 29, 2026Oct 11, 2026Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Anika Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12

Feedback